HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats.

Abstract
Overproduction of NO by an inducible NO synthase (iNOS) plays a role in the pathophysiology of septic shock. In such situations, NOS inhibition might be of therapeutic value, although detrimental side effects possibly related to inhibition of constitutive NOS have been reported. The use of L-canavanine, a selective inhibitor of iNOS, might be more suitable. The aim of the study was to compare in a rodent endotoxic shock the effects of saline (2 mL/h), N(G)-methyl-L-arginine(L-NMMA) (10 mg/kg/h) and L-canavanine (100 mg/kg/h) on muscle intracellular pH (pHi) and intracellular bioenergetic patterns (ATP, phosphocreatine/inorganic phosphate ratio) using in vivo 31P magnetic resonance spectroscopy (31P MRS). Three groups of anesthetized, mechanically ventilated and paralyzed rats received an intravenous infusion of 15 mg/kg of endotoxin. A fourth time-matched control group (n = 8) received 2 mL/h of saline. Mean arterial pressure, femoral blood flow, arterial blood gases, lactate, nitrate level, and 31P nuclear magnetic resonance (31P MRS) measurements were acquired at onset (T = 0), 90 min (T = 90), and 180 min (T180) after the endotoxin challenge. Femoral oxygen delivery was calculated as the product of femoral blood flow (mL/min) and arterial oxygen content. Endotoxin induced a marked decrease in arterial pressure and femoral oxygen delivery and an increase in lactate level. Intracellular pH and phosphocreatine/inorganic phosphate ratio decreased. ATP level did not change. Both L-NMMA and L-canavanine reversed the endotoxin-induced decrease in arterial pressure. L-NMMA attenuated the decrease in femoral oxygen delivery and the increase in lactate level while these were corrected by L-canavanine. Considering 31P MRS derived bioenergetic indices, the endotoxin-induced decrease in pHi and Pcr/Pi was attenuated by L-NMMA and corrected by L-canavanine. In conclusion, in a rodent model of endotoxinic shock, the continuous infusion of L-canavanine, a selective iNOS inhibitor, improved the systemic hemodynamic parameters and the intracellular bio-energetic patterns estimated by in vivo 31P MRS. To the contrary, the continuous infusion of both constitutive and inducible NOS inhibitor L-NMMA was not followed by the same achievement.
AuthorsB Levy, M Valtier, C de Chillou, P E Bollaert, D Cane, J P Mallie
JournalShock (Augusta, Ga.) (Shock) Vol. 11 Issue 2 Pg. 98-103 (Feb 1999) ISSN: 1073-2322 [Print] United States
PMID10030795 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Lipopolysaccharides
  • Nitrates
  • Phosphates
  • Phosphorus Isotopes
  • Phosphocreatine
  • omega-N-Methylarginine
  • Lactic Acid
  • Canavanine
  • Sodium Chloride
  • Adenosine Triphosphate
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Canavanine (pharmacology)
  • Energy Metabolism (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Hydrogen-Ion Concentration
  • Lactic Acid (metabolism)
  • Lipopolysaccharides
  • Muscle, Skeletal (drug effects, metabolism)
  • Nitrates (metabolism)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Nitric Oxide Synthase Type II
  • Phosphates (metabolism)
  • Phosphocreatine (analysis, metabolism)
  • Phosphorus Isotopes
  • Rats
  • Rats, Sprague-Dawley
  • Shock, Septic (chemically induced, drug therapy, metabolism)
  • Sodium Chloride (pharmacology)
  • Spectrum Analysis (methods)
  • omega-N-Methylarginine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: